| Literature DB >> 35240943 |
Walid Al-Qerem1, Abdel Qader Al Bawab1, Alaa Hammad1, Tasneem Jaber1, Sawsan I Khdair1, Haneen Kalloush1, Jonathan Ling2, Rami Mosleh3.
Abstract
The question of whether children should be vaccinated against COVID-19 is currently being argued. The risk-benefit analysis of the vaccine in children has been more challenging because of the low prevalence of acute COVID-19 in children and the lack of confidence in the relative effects of the vaccine and the disease. One of the most convincing arguments for vaccinating healthy children is to protect them from long-term consequences. The aim of this study was to assess Jordanian parents' intention to vaccinate their children. This is an Internet-based cross-sectional survey. The researchers prepared a Google Forms survey and shared the link with a number of Jordanian Facebook generic groups. Data were gathered between September and November 2021. In this study, convenience sampling was used. Knowledge about COVID-19 and preventive practices against COVID-19 were calculated for each participant. A total of 819 participants completed the survey (female = 70.9%). Of these, 274 (30.2%) participants intended to vaccinate their children, whereas the rest were either unsure 176 (21.5%) or intended not to vaccinate their children 396 (48.4%). The variables that increased the odds of answering "No" vs "Yes" to "will you vaccinate your children against COVID-19" included not willing to take the vaccines themselves (OR 3.75; CI, 1.46-9.62) and low protective practice group (OR 1.73;CI, 1.12-2.68). Participants had significant levels of refusal/hesitancy. Several barriers to vaccination were identified; attempts to overcome these should be stepped up.Entities:
Keywords: COVID-19; I10; Jordan; children; hesitancy; vaccine
Mesh:
Substances:
Year: 2022 PMID: 35240943 PMCID: PMC9225601 DOI: 10.1080/21645515.2022.2044257
Source DB: PubMed Journal: Hum Vaccin Immunother ISSN: 2164-5515 Impact factor: 4.526
Figure 1.Recruitment flowchart.
Sample characteristics
| Characteristics | Frequency (%) | |
|---|---|---|
| Participant age | 18-29 | 146 (17.8) |
| 30-39 | 344 (42.0) | |
| 40-49 | 196 (23.9) | |
| 50-59 | 122 (14.9) | |
| 60 or more | 11 (1.3) | |
| Children’s age | Under one year | 81 (9.9) |
| 1–3 year | 274 (33.5) | |
| 4–6 year | 318 (38.8) | |
| 7–12 year | 406 (49.6) | |
| 13–17 year | 259 (31.6) | |
| More than 18 years | 144 (17.6) | |
| Sex | Male | 238 (29.1) |
| Female | 581 (70.9) | |
| Marital status | Single | 118 (14.4) |
| Married | 701 (85.6) | |
| Pregnancy status | Yes | 45 (3.4) |
| Child sex | Boys | 204 (24.9) |
| Girls | 148 (18.1) | |
| Boys and girls | 467 (57.0) | |
| Do you Smoke? | No | 619 (75.6) |
| Ex-smoker | 28 (3.4) | |
| Yes | 172 (21.0) | |
| Educational level | High school or less | 149 (18.2) |
| Diploma | 70 (8.5) | |
| University student | 10 (1.2) | |
| Bachelor | 426 (52.0) | |
| Postgrad | 164 (20.0) | |
| Household average monthly income ($) | Less than 700 | 275 (33.6) |
| 700-1400 | 358 (43.7) | |
| More than 1400 | 186 (22.7) | |
| Are you working/studying in a medical field | Yes | 296 (36.1) |
| No | 523 (63.9) | |
| Residency | North region | 161 (19.7) |
| South region | 66 (6.1) | |
| Zarqa | 118 (14.4) | |
| Middle region | 61 (7.4) | |
| Amman | 413 (50.4) |
$: US dollars.
Intention to vaccinate children by different sample characteristics presented as means (SD) or frequencies (percentages)
| A | | | |||
|---|---|---|---|---|---|
| No | Not Sure | Yes | | | |
| (N=396,48.4%) | (N=176,21.5%) | (N=247,30.2%) | Chi-square | P-Value | |
| 3.558 | 0.74 | ||||
| One | 76 (19.2) | 30 (17.0) | 46 (18.6) | ||
| Two | 126 (31.8) | 62 (35.2) | 77 (31.2) | ||
| Three | 78 (19.7) | 42 (23.9) | 50 (20.2) | ||
| Four children or more | 116 (29.3) | 42 (23.9) | 74 (30.0) | ||
| Less than one year | 40 (10.1) | 16 (9.1) | 25 (10.1) | 0.161 | 0.923 |
| 1–3 years | 133 (33.6) | 60 (34.1) | 81 (32.8) | 0.084 | 0.959 |
| 4–6 years | 160 (40.4) | 67 (38.1) | 91 (36.8) | 0.867 | 0.648 |
| 7–12 years | 204 (51.5) | 84 (47.7) | 118 (47.8) | 1.157 | 0.561 |
| 13–17 years | 125 (31.6) | 55 (31.3) | 79 (32.0) | 0.027 | 0.987 |
| 18 years or more | 59 (14.9) | 33 (18.8) | 52 (21.1) | 4.186 | 0.123 |
| 4.743 | 0.78 | ||||
| 18-29 | 74 (18.7) | 34 (19.3) | 38 (15.4) | ||
| 30-39 | 168 (42.4) | 69 (39.2) | 107 (43.3) | ||
| 40-49 | 95 (24.0) | 45 (25.6) | 56 (22.7) | ||
| 50-59 | 56 (14.1) | 25 (14.2) | 41 (16.6) | ||
| 60 or more | 3 (.8) | 3 (1.7) | 5 (2.0) | ||
| 9.59 | 0.05 | ||||
| Girls | 64 (16.2) | 43 (24.4) | 41 (16.6) | ||
| Boys | 111 (28.0) | 33 (18.8) | 60 (24.3) | ||
| Both (Girls and boys) | 221 (55.8) | 100 (56.8) | 146 (59.1) | ||
| 2.986 | 0.23 | ||||
| Other | 49 (12.4) | 31 (17.6) | 38 (15.4) | ||
| Married | 347 (87.6) | 145 (82.4) | 209 (84.6) | ||
| 22.384 | <.001 | ||||
| North region | 94 (23.7) | 28 (15.9) | 39 (15.8) | ||
| South region | 19 (4.8) | 22 (12.5) | 25 (10.1) | ||
| Zarqa | 56 (14.1) | 32 (18.2) | 30 (12.1) | ||
| Middle region | 26 (6.6) | 12 (6.8) | 23 (9.3) | ||
| Amman | 201 (50.8) | 82 (46.6) | 130 (52.6) | ||
| 0.289 | 0.87 | ||||
| Female | 283 (71.5) | 122 (69.3) | 176 (71.3) | ||
| Male | 113 (28.5) | 54 (30.7) | 71 (28.7) | ||
| 0.895 | 0.93 | ||||
| No | 300 (75.8) | 132 (75.0) | 187 (75.7) | ||
| Ex-smoker | 12 (3.0) | 8 (4.5) | 8 (3.2) | ||
| Yes | 84 (21.2) | 36 (20.5) | 52 (21.1) | ||
| 6.593 | 0.58 | ||||
| High school or less | 66 (16.7) | 37 (21.0) | 46 (18.6) | ||
| University student | 5 (1.3) | 2 (1.1) | 3 (1.2) | ||
| Diploma | 42 (10.6) | 10 (5.7) | 18 (7.3) | ||
| Bachelor’s degree | 210 (53.0) | 90 (51.1) | 126 (51.0) | ||
| Postgrad | 73 (18.4) | 37 (21.0) | 54 (21.9) | ||
| 21.045 | <.001 | ||||
| Less than $700 | 159 (40.2) | 51 (29.0) | 65 (26.3) | ||
| $700-$1400 | 169 (42.7) | 79 (44.9) | 110 (44.5) | ||
| More than $1400 | 68 (17.2) | 46 (26.1) | 72 (29.1) | ||
| 8.184 | 0.02 | ||||
| Yes | 128 (32.3) | 61 (34.7) | 107 (43.3) | ||
| No | 268 (67.7) | 115 (65.3) | 140 (56.7) | ||
| 40 (10.1) | 22 (12.5) | 39 (15.8) | 4.559 | 0.10 | |
| Yes | |||||
| No | 356 (89.9) | 154 (87.5) | 208 (84.2) | ||
| 11.008 | 0.03 | ||||
| No | 164 (41.4) | 77 (43.8) | 99 (40.1) | ||
| Not sure | 44 (11.1) | 21 (11.9) | 12 (4.9) | ||
| Yes | 188 (47.5) | 12 (44.3) | 136 (55.1) | ||
| 10.114 | 0.04 | ||||
| No | 268 (67.8) | 117 (66.5) | 141 (57.6) | ||
| Not sure | 36 (9.1) | 24 (13.6) | 32 (13.1) | ||
| Yes | 91 (23.0) | 32 (19.9) | 72 (29.4) | ||
| 9.483 | 0.05 | ||||
| No | 208 (52.5) | 99 (56.3) | 134 (54.3) | ||
| Not sure | 45 (11.4) | 25 (14.2) | 16 (6.5) | ||
| Yes | 143 (36.1) | 52 (29.5) | 97 (39.3) | ||
| 22.80 | <.001 | ||||
| I do not think that my child will be infected | 129 (32.6) | 45 (25.6) | 77 (31.2) | ||
| I think that my child will be infected and his symptoms will be mild | 190 (48.0) | 101 (57.4) | 141 (57.1) | ||
| I don’t now | 59 (14.9) | 22 (12.5) | 11 (4.5) | ||
| I think that my child will be infected and his symptoms will be severe | 18 (4.5) | 8 (4.5) | 18 (7.3) | ||
| 64 (16.2) | 21 (11.9) | 30 (12.1) | 2.859 | 0.24 | |
| high risk | |||||
| Low risk | 332 (83.8) | 155 (88.1) | 217 (87.9) | ||
| 1.01 | 0.60 | ||||
| Low | 273 (68.9) | 120 (98.2) | 161 (65.2) | ||
| High | 123 (31.1) | 56 (31.8) | 86 (34.8) | ||
| 13.127 | <.001 | ||||
| Low | 252 (63.6) | 107 (60.8) | 122 (49.4) | ||
| High | 144 (36.4) | 69 (39.2) | 125 (50.6) | ||
| 331 (83.6) | 158 (89.8) | 240 (97.2) | 28.814 | <.001 | |
| No | 65 (16.4) | 18 (10.2) | 7 (2.8) | ||
| No | Not Sure | Yes | P-Value | ||
| 2.92 (±1.25) | 3.31 (±1.1) | 3.43 (±1.13) | |||
| <.001 | |||||
| 2.85 (±1.43) | 3.01(±1.03) | 3.39 (±1.22) | <.001 | ||
| 2.11 (±1.08) | 3.00 (±1.03) | 3.47 (±1.06) | <.001 | ||
| 1.69 (±.99) | 2.63 (±.93) | 3.36 (±1.08) | <.001 | ||
Multivariate predictors of responding “not sure” or “no” regarding intent to vaccinate your children
| Characteristics | Intent to vaccinate | Intent to vaccinate |
|---|---|---|
| 0.89 (.71–1.11) | 0.72 (.58–.90)** | |
| 1.11 (.87–1.41) | 1.32 (1.04–1.69)* | |
| 0.76 (.58–.99)* | 1.10 (.84–1.44) | |
| 0.28 (.21–.36)** | 0.52 (.40–.67)** | |
| 1.26 (.70–2.29) | 0.96 (.51–1.83) | |
| South region | 0.44 (.19–1.00)* | 1.39 (.67–2.92) |
| Zarqa | 0.90 (.47–1.73) | 1.74 (.91–3.31) |
| Middle region | 0.7 (.31–1.57) | 0.91 (.40–2.08) |
| Amman | ||
| 1.06 (.58–1.93) | 0.84 (.46–1.55) | |
| $700-$1400 | 1.13(.66–1.93) | 0.98 (.58–1.66) |
| More than $1400 | ||
| 1.03 (.65–1.63) | 0.75 (.47–1.21) | |
| NO | ||
| 0.43 (.23–.81)** | 0.67 (.36–1.27) | |
| NO | ||
| 0.58 (.31–1.07) | 0.65 (.35–1.21) | |
| MAYBE | 3.05 (1.03–8.98)* | 2.12 (.73–6.21) |
| NO | ||
| 1.53 (.83–2.82) | 1.15 (.61–2.17) | |
| MAYBE | 1.09 (.40–2.94) | 1.76 (.66–4.70) |
| NO | ||
| 0.79 (.44–1.41) | 0.78 (.43–1.43) | |
| MAYBE | 0.32 (.14–.69)** | 0.53 (.24–1.14) |
| NO | ||
| I think that my child will be infected and his symptoms will be severe | 0.52 (.57–3.86) | 1.33 (.47–3.75) |
| I don’t know | 2.72 (1.10–6.71)* | 4.09 (1.63–10.24)** |
| I think that my child will be infected and his symptoms will be mild | 1.03 (.63–1.66) | 1.39 (.84–2.28) |
| I do not think that my child will be infected | ||
| 1.73 (1.12–2.68)** | 1.53 (.99–2.38) | |
| High | ||
| 3.75 (1.46–9.62)** | 2.78 (1.04–7.42)* | |
| YES | ||
| 1.45 (.81–2.61) | 1.75 (.99–3.09) | |
| Boys | 1.13 (.66–1.90) | 0.67 (.38–1.19) |
| Both (boys and girls) |
* Significant at the level of less than .05, ** Significant at the level of less than .01.
Reasons participants provided for responding “No” or “Not sure” regarding intent to be vaccinated
| Reasons | Total N (%) |
|---|---|
| The vaccine will be new, I won’t be the first to get the vaccine | 544 (95.0) |
| Vaccine cause autism | 87 (15.2) |
| I don’t think that I can afford the vaccine | 113 (19.7) |
| Vaccination may cause infected disease | 363 (63.5) |
| I don’t want the vaccine I know nothing about. I’ll make my decision if/when on become available | 506 (88.5) |
| I don’t feel I’m at risk | 259 (45.3) |
| I am scared to put forge in object on my body | 496 (86.7) |
| If the government recommended it use I will not take it | 350 (61.2) |
| There is no way I trust big pharmaceutical company | 310 (54.2) |
| I believe that this virus was developed by the governments and I won’t take any vaccine | 278 (48.6) |
Knowledge toward COVID-19 and its vaccines
| Variable | Frequency (%) |
|---|---|
|
| |
|
| |
| Fever | 1116 (97.6) |
| Chills | 802 (70.1) |
| Diarrhea | 815 (71.2) |
| Cough | 1033 (90.3) |
| Otitis media | 234 (20.5) |
| Loss of smell and taste senses | 1107 (96.8) |
| No symptoms | 1017 (88.9) |
|
| |
| Drinking unclean water | 153 (13.4) |
| Eating unclean food | 217 (19.0) |
| Inhalation of respiratory droplets of infected person | 1135 (99.2) |
| Eating or touching wild animals | 255 (22.3) |
|
| |
| Wearing face masks | 1078 (94.2) |
| Washing hands with regular soap | 1075 (94.0) |
| Using detergents | 1084 (94.8) |
| Social distancing | 1116 (97.6) |
| Avoid touching face/mouth/nose/eyes | 1091 (95.4) |
| Avoid eating meat | 143 (12.5) |
| Consume herbs | 594 (52.2) |
| Believe that there is a cure for COVID19‡ | 22 (1.9) |
| Identified all the possible side effects of the vaccine included in the options correctly | 176(21.5%) |
| Vaccine is given intramuscularly | 621(75.8) |
|
| |
|
| |
| Wearing face masks* | 1101 (96.2) |
| Washing hands with regular soap* | 1091 (95.4) |
| Using detergents* | 1070 (93.5) |
| Social distancing* | 1035 (90.5) |
| Avoid touching face/mouth/nose/eyes* | 936 (81.8) |
†Correct information,‡ Incorrect information, *Scientifically proven protective measure against COVID19.